Expression of the c-Met Proto-Oncogene and Integrin α5β1 in Human Gastric Cardia Adenocarcinoma

被引:21
作者
Chi, Fusheng [1 ,2 ]
Fu, Da [3 ]
Zhang, Xiaoping [3 ]
Lv, Zhongwei [3 ]
Wang, Zhesheng [1 ,2 ]
机构
[1] China Med Univ, Hosp 1, Dept Gen Surg, Shenyang 110001, Peoples R China
[2] Peoples Hosp Liaoning Prov, Dept Thorac Surg, Shenyang 110016, Peoples R China
[3] Tongji Univ, Peoples Hosp 10, Dept Nucl Med, Shanghai 200072, Peoples R China
关键词
c-Met; Integrin alpha 5 beta 1; expression; cardia adenocarcinoma; ESOPHAGEAL; CANCER; CARCINOMA; GROWTH; ALPHA(5)BETA(1); OVEREXPRESSION; RECEPTOR;
D O I
10.1271/bbb.120132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The hepatocyte growth factor receptor c-Met, a receptor tyrosine kinase, and Integrin alpha 5 beta 1, one of the main ECM receptors of hepatocytes have been reported to play important roles in tumor growth by activating mitogenic signaling pathways. In human gastric cardia adenocarcinoma, however, expression of the c-Met and Integrin alpha 5 beta 1 have not been reported. Here we examined the mRNA levels and protein expressions of these two genes and their relationship in human normal gastric cardia mucosa and primary carcinomas. Quantitative real-time PCR was used to analyze the mRNA expression of both c-Met and Integrin alpha 5 beta 1. The relationship between c-Met and Integrin alpha 5 beta 1 expression and the histologic characteristics of tumors were studied. Western blot analysis was performed to investigate the presence of c-Met and Integrin alpha 5 beta 1. The expression patterns of c-Met and Integrin alpha 5 beta 1 in 45 frozen slides of cardia adenocarcinoma were identified by immunohistochemistry. Our results indicate that the expression of c-Met and of Integrin alpha 5 beta 1 was significantly associated with tumor differentiation, TNM, and metastasis via the lymphogenic route. A significant positive correlation was also found between c-Met and Integrin alpha 5 beta 1 mRNA expression, suggesting that expression of c-Met and Integrin alpha 5 beta 1 has mechanical significance in the early stages of human gastric cardia adenocarcinoma.
引用
收藏
页码:1471 / 1476
页数:6
相关论文
共 24 条
[1]
Met, metastasis, motility and more [J].
Birchmeier, C ;
Birchmeier, W ;
Gherardi, E ;
Vande Woude, GF .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) :915-925
[2]
Integrin signalling adaptors: not only figurants in the cancer story [J].
Cabodi, Sara ;
Camacho-Leal, Maria del Pilar ;
Di Stefano, Paola ;
Defilippi, Paola .
NATURE REVIEWS CANCER, 2010, 10 (12) :858-870
[3]
Pathway specificity for Met signalling [J].
Comoglio, PM .
NATURE CELL BIOLOGY, 2001, 3 (07) :E161-E162
[4]
Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment [J].
DeMeester, SR .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (01) :12-30
[5]
Garcia S, 2007, INT J ONCOL, V31, P49
[6]
Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma-a systematic review and meta-analysis [J].
Islami, F. ;
Sheikhattari, P. ;
Ren, J. S. ;
Kamangar, F. .
ANNALS OF ONCOLOGY, 2011, 22 (04) :754-760
[7]
Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis [J].
Kubo, Ai ;
Corley, Douglas A. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (05) :872-878
[8]
Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity [J].
Li, Gang ;
Zhang, Lianglin ;
Chen, Enhong ;
Wang, Jianying ;
Jiang, Xin ;
Chen, Jeffrey H. ;
Wickman, Grant ;
Amundson, Karin ;
Bergqvist, Simon ;
Zobel, James ;
Buckman, Dana ;
Baxi, Sangita M. ;
Bender, Steven L. ;
Casperson, Gerald F. ;
Hu-Lowe, Dana D. .
CANCER RESEARCH, 2010, 70 (24) :10243-10254
[9]
Rapid access of antibodies to α5β1 integrin overexpressed on the luminal surface of tumor blood vessels [J].
Magnussen, A ;
Kasman, IM ;
Norberg, S ;
Baluk, P ;
Murray, R ;
McDonald, DM .
CANCER RESEARCH, 2005, 65 (07) :2712-2721
[10]
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition [J].
Maulik, G ;
Shrikhande, A ;
Kijima, T ;
Ma, PC ;
Morrison, PT ;
Salgia, R .
CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) :41-59